Nuzenio

Phil Nadeau Reiterates

Phil Nadeau Reiterates news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Analyst Reiterates Buy on Vir Biotechnology, Citing Advancing Hepatitis D and Oncology Pipelines and Strong Cash Runway - TipRanksTipRanks · Thu, 06 Aug 2026 16:34:38 GMT Phil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst - TipRanksTipRanks · Thu, 06 Aug 2026 10:36:07 GMT Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Trajectory and Potential $2B Peak U.S. Sales - TipRanksTipRanks · Tue, 04 Aug 2026 07:00:00 GMT RBC Capital Sticks to Their Buy Rating for Biogen (BIIB) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 07:00:00 GMT Phil Nadeau Raises Neurocrine Price Target to $220 on Exceptional Q2 Beat and Strength Across Ingrezza and Crenessity - TipRanksTipRanks · Fri, 31 Jul 2026 04:24:17 GMT

Timeline

Thu, 06 Aug 2026 16:34:38 GMTAnalyst Reiterates Buy on Vir Biotechnology, Citing Advancing Hepatitis D and Oncology Pipelines and Strong Cash Runway - TipRanks

Thu, 06 Aug 2026 10:36:07 GMTPhil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst - TipRanks

Tue, 04 Aug 2026 07:00:00 GMTPhil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Trajectory and Potential $2B Peak U.S. Sales - TipRanks

Fri, 31 Jul 2026 07:00:00 GMTRBC Capital Sticks to Their Buy Rating for Biogen (BIIB) - The Globe and Mail

Fri, 31 Jul 2026 04:24:17 GMTPhil Nadeau Raises Neurocrine Price Target to $220 on Exceptional Q2 Beat and Strength Across Ingrezza and Crenessity - TipRanks

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Buy3 live mentions TipRanks Phil Nadeau3 live mentions Vir Biotechnology2 live mentions Citing Advancing Hepatitis2 live mentions Oncology Pipelines2 live mentions Strong Cash Runway2 live mentions Editas Medicine2 live mentions Citing Strong Cash2 live mentions Runway2 live mentions Upcoming EDIT2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phil Nadeau Reiterates.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.